← FDA WARNING LETTERS
FDA WARNING LETTER20 March 2017

ImprimisRx CA, Inc., dba ImprimisRx — FDA Warning Letter

Company
ImprimisRx CA, Inc., dba ImprimisRx
Letter date
20 March 2017
CHECKING ACCESS

Checking your Professional access…

DON’T BE THE NEXT LETTER
Assess your quality systemBaseline against 12 GxP domains in 10 minutes →Decode the standardsThe requirements behind the citations →All warning lettersBrowse the live FDA feed →

Warning-letter details are published by the U.S. FDA; SPEQ surfaces them for reference and is not affiliated with or endorsed by the FDA. The authoritative text is on fda.gov.